90 results
Page 2 of 5
6-K
EX-99
zq9d 4wm3s2xde
16 Aug 22
BioLineRx Reports Second Quarter 2022 Financial Results
7:19am
6-K
EX-99
8h6qx1x444uh9bim0aa
11 May 22
BioLineRx Reports First Quarter 2022 Financial Results
7:14am
6-K
EX-99
9748n1j6 pj
16 Mar 22
BioLineRx Reports Fourth Quarter 2021 Financial Results
7:11am
6-K
EX-99
x2xid 06pihkifs9zp
17 Dec 21
BioLineRx Provides Highlights from Oral Presentation
7:10am
6-K
EX-99
0jvw q7k51k
15 Dec 21
BioLineRx Announces Formation of Immuno-Oncology
7:25am
6-K
EX-99
5675cwo
18 Nov 21
BioLineRx Reports Third Quarter 2021 Financial Results
7:16am
6-K
EX-99
0b7ab
18 Nov 21
BioLineRx Reports Third Quarter 2021 Financial Results
7:16am
6-K
EX-1
lgki a8oass
4 Nov 21
BioLineRx Announces an Oral Presentation and Three
10:15am
6-K
EX-99
bdg2lfp7
18 Aug 21
BioLineRx Reports Second Quarter 2021 Financial Results
7:01am
6-K
EX-99
e8e8r 7lhq
26 May 21
BioLineRx Reports First Quarter 2021 Financial Results
7:54am
424B5
be0h8k5
21 Jan 21
Prospectus supplement for primary offering
4:31pm
424B5
0pxcgi40
19 Jan 21
Prospectus supplement for primary offering
5:00pm
F-3
ubi2l7ng
31 Dec 20
Shelf registration (foreign)
4:37pm
424B5
06ju73nbztcmofaswa
31 Dec 20
Prospectus supplement for primary offering
4:31pm
6-K
EX-99
gkobl xgq3r7y
23 Nov 20
BioLineRx Reports Third Quarter 2020 Financial Results
7:08am
424B5
6lnnsznxb1at ha2l96
13 Nov 20
Prospectus supplement for primary offering
4:31pm
424B5
1dujt311uz mgd
25 Sep 20
Prospectus supplement for primary offering
4:30pm